Weight Loss
Semaglutide, Tirzepatide, Retatrutide, Tesofensine, AOD-9604 — the most-researched compounds driving the weight-loss conversation.
AOD-9604
Fragment 176–191
Modified hGH fragment 176–191 research peptide — widely studied in adipose-tissue and lipolytic-pathway research, in a Vivaprime prefilled pen.
Retatrutide
Triple Agonist (GIP/GLP-1/Glucagon)
Triple GIP/GLP-1/glucagon receptor agonist research peptide — the most-anticipated next-generation metabolic compound, in a Vivaprime prefilled pen.
Semaglutide
GLP-1 Receptor Agonist
A long-studied GLP-1 receptor agonist research peptide in an EU-manufactured prefilled pen — no reconstitution, no dose calculation, 99%+ purity per batch.
Tesofensine
Triple monoamine reuptake-inhibition research compound — frequently studied alongside GLP-1s for comparative metabolic research. EU-manufactured prefilled pen.
Tirzepatide
Dual GIP/GLP-1 Agonist
Dual GIP/GLP-1 receptor agonist research peptide — the next-generation metabolic compound, in an EU-manufactured prefilled pen with per-batch COA.